Animal Dermatology Group congratulates newest ACVD diplomates

Animal Dermatology Group, Inc. recently congratulated the newest group of veterinarians who have reached diplomate status with the American College of Veterinary Dermatology. Six of the new diplomates are members of the Animal Dermatology Group’s medical team, according to a news release

New diplomates are specialists in the diagnosis and treatment of chronic dermatological conditions, including benign and malignant disorders of the skin, hair, ears and nails in animals. They join board-certified veterinary dermatologists practicing in the U.S. and throughout the world.

"We take great pride in our commitment to the clinical practice of veterinary dermatology as well as the training and development of the next generation of specialists in our field," stated Dr. Rusty Muse, medical director of American Dermatology Group, in the news release. "We congratulate the new board-certified veterinary dermatologists and welcome them to our exciting and deeply rewarding specialty of veterinary medicine."

American Dermatology Group medical team members who are part of the ACVD's newest class of diplomates and are employed at Animal Dermatology clinics include Drs. Kelsey Milich, M. Kelly Keating, Melissa Loewinger, Henrietta Parnell-Turner, Katlyn Robertson and Marvin Daniel Schuldenfrei.

American Dermatology Group was the first non-academic organization accredited by the ACVD to provide a residency training program and today hosts the largest ACVD residency classes preparing future board certified dermatologists.

The ACVD is accredited by the American Veterinary Medical Association and responsible for maintaining post-graduate training and certification standards for the veterinary dermatology specialty in the U.S. It mandates a rigorous curriculum of specialized training for veterinarians seeking to become board-certified veterinary dermatologists.

  • Please enter a comment

Name *
Email address *
Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

More news

World Veterinary Dermatology Day


Artificial insemination market to grow to $3B by 2028


February is National Pet Dental Health Month


Falling markets? Don't panic, it's not the first time


Treatment of canine chronic cutaneous lupus erythematosus with oclacitinib




News of interest


Copyright © 2023 - All Rights Reserved
ISSN 2768-198X